Location: Afghanistan

 A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing  Elaborate profiles of some of the key contract manufacturers active in the pharmaceutical and biopharmaceutical continuous... Read More

Advances in screening technologies have enabled the identification of interactive gene combinations, enabling the development of lead candidates that leverage the principle of synthetic lethality for cancer treatment To... Read More

 A detailed assessment of the current market landscape of targeted protein degradation-based therapeutics, providing information on drug / therapy developer(s) (such as year of establishment, company size and location of... Read More

 Over 32,000 patents related to RNAi therapeutics, indicating the heightened pace of research, have been filed / granted in the last several years  Presently, there is only one approved drug and... Read More

In recent years, the concept of STING pathway targeting therapeutics has generated a lot of enthusiasm within the medical science community. The growing popularity of this therapeutic technique has not... Read More

 A detailed assessment of the overall novel vaccine delivery devices market landscape, featuring an elaborate list of device developers engaged in the development of novel vaccine delivery devices.  A detailed competitiveness... Read More

 A detailed assessment of the current market landscape of companies offering peptide and macrocycle drug discovery services  An insightful geographical benchmarking of the capabilities of companies of various sizes, highlighting the... Read More

 A detailed review of the ophthalmic drugs contract manufacturing market landscape, featuring a list of over 240 CMOs and analysis based on a number of relevant parameters.  A competitiveness analysis of... Read More

Currently, more than 60 drugs are marketed / under development for PCOS More than 80% of the drugs in the market are designed for symptomatic treatment of PCOS whilst a few... Read More

Over 80 TIL-based therapies are currently under development Close to 55% of the aforementioned candidates are being evaluated in clinical stages (phase I/II and above), while more than 20% therapies... Read More